GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Lumibird (XPAR:LBIRD) » Definitions » Total Liabilities

Lumibird (XPAR:LBIRD) Total Liabilities : €185.61 Mil (As of Jun. 2023)


View and export this data going back to 1997. Start your Free Trial

What is Lumibird Total Liabilities?

Lumibird's Total Liabilities for the quarter that ended in Jun. 2023 was €185.61 Mil.

Lumibird's quarterly Total Liabilities increased from Jun. 2022 (€172.31 Mil) to Dec. 2022 (€178.61 Mil) and increased from Dec. 2022 (€178.61 Mil) to Jun. 2023 (€185.61 Mil).

Lumibird's annual Total Liabilities increased from Dec. 2020 (€141.35 Mil) to Dec. 2021 (€166.30 Mil) and increased from Dec. 2021 (€166.30 Mil) to Dec. 2022 (€178.61 Mil).


Lumibird Total Liabilities Historical Data

The historical data trend for Lumibird's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lumibird Total Liabilities Chart

Lumibird Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.81 141.35 166.30 178.61 211.90

Lumibird Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 166.30 172.31 178.61 185.61 211.90

Lumibird Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Lumibird's Total Liabilities for the fiscal year that ended in Dec. 2022 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=119.845+(48.618+7.041
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+3.102)
=178.61

Total Liabilities=Total Assets (A: Dec. 2022 )-Total Equity (A: Dec. 2022 )
=372.044-193.438
=178.61

Lumibird's Total Liabilities for the quarter that ended in Jun. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=73.334+(103.726+5.466
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+0+3.084)
=185.61

Total Liabilities=Total Assets (Q: Jun. 2023 )-Total Equity (Q: Jun. 2023 )
=374.17-188.56
=185.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Lumibird Total Liabilities Related Terms

Thank you for viewing the detailed overview of Lumibird's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Lumibird (XPAR:LBIRD) Business Description

Traded in Other Exchanges
Address
2 rue du Paul Sabatier, Lannion, FRA, 22300
Lumibird, formerly Quantel SA is an enterprise engaged in the designing, manufacturing, and sale of scientific laser solutions. Scientific and industrial applications lasers used by research laboratories in the study of material, cleaning lasers, marking, measurement, and others. whereas, Medical applications include specialized lasers for ophthalmology, dermatology, and esthetics. The company generates a majority of its revenue from the scientific and industrial applications.

Lumibird (XPAR:LBIRD) Headlines

No Headlines